These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 14522142

  • 1. Alpha-synuclein oligomerization: a role for lipids?
    Welch K, Yuan J.
    Trends Neurosci; 2003 Oct; 26(10):517-9. PubMed ID: 14522142
    [Abstract] [Full Text] [Related]

  • 2. The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease.
    Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ.
    Neuron; 2003 Feb 20; 37(4):583-95. PubMed ID: 12597857
    [Abstract] [Full Text] [Related]

  • 3. Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease.
    Hegde ML, Jagannatha Rao KS.
    Arch Biochem Biophys; 2003 Oct 15; 418(2):169-78. PubMed ID: 14522588
    [Abstract] [Full Text] [Related]

  • 4. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, Jakes R, Crowther RA.
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb 28; 356(1406):213-27. PubMed ID: 11260802
    [Abstract] [Full Text] [Related]

  • 5. alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?
    Lee SJ.
    Antioxid Redox Signal; 2003 Jun 28; 5(3):337-48. PubMed ID: 12880487
    [Abstract] [Full Text] [Related]

  • 6. Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?
    Rajagopalan S, Andersen JK.
    Mech Ageing Dev; 2001 Sep 30; 122(14):1499-510. PubMed ID: 11511392
    [Abstract] [Full Text] [Related]

  • 7. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.
    Arawaka S, Saito Y, Murayama S, Mori H.
    Neurology; 1998 Sep 30; 51(3):887-9. PubMed ID: 9748051
    [Abstract] [Full Text] [Related]

  • 8. Copper(II)-induced self-oligomerization of alpha-synuclein.
    Paik SR, Shin HJ, Lee JH, Chang CS, Kim J.
    Biochem J; 1999 Jun 15; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
    [Abstract] [Full Text] [Related]

  • 9. Pathogenic effects of alpha-synuclein aggregation.
    Lundvig D, Lindersson E, Jensen PH.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):3-17. PubMed ID: 15790525
    [Abstract] [Full Text] [Related]

  • 10. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders.
    Uversky VN.
    J Biomol Struct Dyn; 2003 Oct 24; 21(2):211-34. PubMed ID: 12956606
    [Abstract] [Full Text] [Related]

  • 11. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
    Krüger R, Müller T, Riess O.
    J Neural Transm (Vienna); 2000 Oct 24; 107(1):31-40. PubMed ID: 10809401
    [Abstract] [Full Text] [Related]

  • 12. Alpha-synuclein aggregation.
    Bodles AM, Irvine GB.
    Protein Pept Lett; 2004 Jun 24; 11(3):271-9. PubMed ID: 15182228
    [Abstract] [Full Text] [Related]

  • 13. Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments.
    Cole NB, Murphy DD, Lebowitz J, Di Noto L, Levine RL, Nussbaum RL.
    J Biol Chem; 2005 Mar 11; 280(10):9678-90. PubMed ID: 15615715
    [Abstract] [Full Text] [Related]

  • 14. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M, Rockenstein E, Crews L, Masliah E.
    Neuromolecular Med; 2003 Mar 11; 4(1-2):21-36. PubMed ID: 14528050
    [Abstract] [Full Text] [Related]

  • 15. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
    Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL.
    Proc Natl Acad Sci U S A; 2002 Jun 25; 99(13):8968-73. PubMed ID: 12084935
    [Abstract] [Full Text] [Related]

  • 16. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
    Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T.
    Nat Cell Biol; 2002 Feb 25; 4(2):160-4. PubMed ID: 11813001
    [Abstract] [Full Text] [Related]

  • 17. Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease?
    Shtilerman MD, Ding TT, Lansbury PT.
    Biochemistry; 2002 Mar 26; 41(12):3855-60. PubMed ID: 11900526
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alpha-synuclein: normal function and role in neurodegenerative diseases.
    Norris EH, Giasson BI, Lee VM.
    Curr Top Dev Biol; 2004 Mar 26; 60():17-54. PubMed ID: 15094295
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.